- Home
- GDEN vs AVDL Comparison
GDEN vs AVDL Comparison
Compare GDEN & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEN
- AVDL
- Stock Information
- Founded
- GDEN 1998
- AVDL 2015
- Country
- GDEN United States
- AVDL Ireland
- Employees
- GDEN N/A
- AVDL N/A
- Industry
- GDEN Services-Misc. Amusement & Recreation
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- GDEN Consumer Discretionary
- AVDL Health Care
- Exchange
- GDEN Nasdaq
- AVDL Nasdaq
- Market Cap
- GDEN 705.7M
- AVDL 784.6M
- IPO Year
- GDEN 1999
- AVDL 1996
- Fundamental
- Price
- GDEN $27.32
- AVDL $9.39
- Analyst Decision
- GDEN Strong Buy
- AVDL Strong Buy
- Analyst Count
- GDEN 7
- AVDL 7
- Target Price
- GDEN $36.86
- AVDL $18.86
- AVG Volume (30 Days)
- GDEN 152.9K
- AVDL 1.2M
- Earning Date
- GDEN 05-08-2025
- AVDL 05-07-2025
- Dividend Yield
- GDEN 3.85%
- AVDL N/A
- EPS Growth
- GDEN N/A
- AVDL N/A
- EPS
- GDEN 0.39
- AVDL N/A
- Revenue
- GDEN $653,614,000.00
- AVDL $194,450,000.00
- Revenue This Year
- GDEN $2.32
- AVDL $50.53
- Revenue Next Year
- GDEN $2.80
- AVDL $32.33
- P/E Ratio
- GDEN $66.78
- AVDL N/A
- Revenue Growth
- GDEN N/A
- AVDL 252.64
- 52 Week Low
- GDEN $22.66
- AVDL $6.38
- 52 Week High
- GDEN $35.49
- AVDL $17.85
- Technical
- Relative Strength Index (RSI)
- GDEN 58.80
- AVDL 64.66
- Support Level
- GDEN $25.28
- AVDL $8.55
- Resistance Level
- GDEN $26.67
- AVDL $9.98
- Average True Range (ATR)
- GDEN 0.85
- AVDL 0.51
- MACD
- GDEN 0.20
- AVDL 0.10
- Stochastic Oscillator
- GDEN 83.40
- AVDL 72.04
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.